Clinical trials recruiting for Plaque Psoriasis
25
Recruiting trials
36
US states with sites
30
Countries
16%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Florida | 6 |
| California | 5 |
| Ohio | 5 |
| Texas | 5 |
| Arizona | 4 |
| Illinois | 4 |
| Massachusetts | 4 |
| Michigan | 4 |
| New York | 4 |
| Alabama | 3 |
| Kentucky | 3 |
| Maryland | 3 |
Top cities
Fountain Valley, California 5Miami, Florida 5Los Angeles, California 4New York, New York 4Phoenix, Arizona 4Birmingham, Alabama 3Canton, Ohio 3Detroit, Michigan 3Fairborn, Ohio 3Houston, Texas 3
Self-screener
Recruiting trials
- A Clinical Study to Evaluate the Efficacy and Safety of D-2570 in the Treatment of Moderate to Severe Plaque Psoriasis
- A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis
- A Phase 3 Clinical Study of QL2106 Injection
- A Study of UA026 Tablets in Healthy Adult Subjects and Adult Subjects With Moderate to Severe Plaque Psoriasis
- A Study of the Comparative Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in Japan (RePhlect)
- A Study to Assess the Effects of Switching From a Biologic Treatment to Tildrakizumab Using Patient-reported Outcomes in Adult Participants With Moderate to Severe Plaque Psoriasis
- A Study to Estimate Secukinumab Retention Rate in Psoriasis Patients With MASLD
- A Study to Evaluate Effectiveness and Safety of a TYK2 Inhibitor in Subjects With Moderate to Severe Plaque Psoriasis
- A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis
- A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis
- A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of ASC50 Tables in Healthy Participants and Participants With Plaque Psoriasis
- A Trial to Understand How Safe and Well Tolerated ZP9830 is and How it Works in People With Plaque Psoriasis Over an 8-week Treatment Period
- An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
- Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers
- Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis
- Efficacy and Safety of ICP-332 Versus Placebo in Participants With Moderate to Severe Plaque Psoriasis
- Efficacy and Safety of Jiuweihuaban Pill for Treating Plaque Psoriasis
- Evaluate the Efficacy and Safety of D-2570 in Subjects With Moderate to Severe Plaque Psoriasis
- Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
- Modifying PEST for Psoriatic Arthritis Screening
- Outcomes With Treatment and Withdraw of Ixekizumab in Patients With Plaque Psoriasis
- ROLL'YN-UST: an Observational Study in Patients Treated by Steqeyma®, an Ustekinumab Biosimilar
- Study to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants With Moderate-to-Severe Plaque Psoriasis
- Triamcinolone With Vitamin D Synergistic Efficacy in Psoriasis
Related conditions
Trials recruiting for Plaque Psoriasis often also study these conditions. Each links to its own recruiting-trial list.
Psoriasis 233Psoriatic arthritis 45Palmoplantar Pustulosis 4Moderate to Severe Plaque Psoriasis 5Metabolic Dysfunction-Associated Steatotic Liver Disease 13Hidradenitis Suppurativa 7Healthy Volunteer 19Eczema 196Crohn's disease 328Chronic Hand Eczema 3
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Plaque Psoriasis trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.